glp 1 agonisté GLP-1 Receptor Agonists: The New Wave in Diabetes Management GLP-1 Agonists: A Comprehensive Overview

Specifically, the ELIXA (lixisenatide) trial studied patients with T2DM who had recent acute coronary syndrome and found that the addition of lixisenatide to conventional therapy did not result in a significant difference in cardiovascular endpoints relative to placebo (Table 1) [56]

Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease

Aslam, M

GLP-1RAs have recently been shown to mitigate these processes by enhancing DNA repair and stabilizing RNA metabolism

Lancet Digit

Theres also research on psyllium fiber and feeling full and a highly viscous non-starch polysaccharide complex called PGX that increases [self-reported] feelings of satiety. But lets get real, he says